Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 824-341-7 | CAS number: 357338-13-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 Feb 2019 - 05 Feb 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- October 09, 2017
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
- Version / remarks:
- 14 February 2017
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- (S)-2-(5-Oxo-3-propyl-1,2-dihydropyrrol-1-yl) butyramide
- Cas Number:
- 357338-13-7
- Molecular formula:
- C11H18N2O2
- IUPAC Name:
- (S)-2-(5-Oxo-3-propyl-1,2-dihydropyrrol-1-yl) butyramide
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Appearance: Off-white powder
- Storage condition of test material: In refrigerator protected from light
Constituent 1
Test system
- Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL: 750 µL of a 20% (w/v) solution in physiological saline per cornea
POSITIVE CONTROL: 750 µL of a 20% (w/v) Imidazole solution in physiological saline per cornea
NEGATIVE CONTROL: 750 µL of physiological saline per cornea - Duration of treatment / exposure:
- 4 hours (at 32°C)
- Duration of post- treatment incubation (in vitro):
- Not applicable
- Number of animals or in vitro replicates:
- 3 corneas for each treatment group
- Details on study design:
- SELECTION, PREPARATION AND QUALITY CHECK OF CORNEAS
- Bovine eyes from young cattle were obtained from the slaughterhouse (Vitelco, 's Hertogenbosch, The Netherlands), where the eyes were excised by a slaughterhouse employee as soon as possible after slaughter. Eyes were collected and transported in physiological saline in a suitable container under cooled conditions.
- The eyes were checked for unacceptable defects, such as opacity, scratches, pigmentation and neovascularization by removing them from the physiological saline and holding them in the light. Corneas with those exhibiting defects were discarded.
- The isolated corneas were stored in a petri dish with cMEM (Earle’s Minimum Essential Medium (Life Technologies, Bleiswijk, The Netherlands) containing 1% (v/v) L-glutamine (Life Technologies) and 1% (v/v) Fetal Bovine Serum (Life Technologies)). The isolated corneas were mounted in a corneal holder (one cornea per holder) of BASF (Ludwigshafen, Germany) with the endothelial side against the O-ring of the posterior half of the holder. The anterior half of the holder was positioned on top of the cornea and tightened with screws. The compartments of the corneal holder were filled with cMEM of 32 ± 1°. The corneas were incubated for the minimum of 1 hour at 32 ± 1°C.
- After the incubation period, the medium was removed from both compartments and replaced with fresh cMEM. Opacity determinations were performed on each of the corneas using an opacitometer (BASF-OP3.0, BASF, Ludwigshafen, Germany). The opacity of each cornea was read against a cMEM filled chamber, and the initial opacity reading thus determined was recorded. Corneas that had an initial opacity reading higher than 7 were not used. Three corneas were selected at random for each treatment group.
TREATMENT
The medium from the anterior compartment was removed and 750 µL of either the negative control, positive control (20% (w/v) Imidazole solution) or 20% (w/v) solution of the test item was introduced onto the epithelium of the cornea. The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the solutions over the entire cornea. Corneas were incubated in a horizontal position for 240 ± 10 minutes at 32 ± 1°C.
REMOVAL OF TEST SUBSTANCE
After the incubation the solutions were removed and the epithelium was washed at least three times with MEM with phenol red (Earle’s Minimum Essential Medium Life Technologies). Possible pH effects of the test item on the corneas were recorded. Each cornea was inspected visually for dissimilar opacity patterns. The medium in the posterior compartment was removed and both compartments were refilled with fresh cMEM and the opacity determinations were performed.
OPACITY
The opacity of a cornea was measured by the diminution of light passing through the cornea. The change in opacity for each individual cornea was calculated (also for the negative control), by subtracting the initial opacity reading from the final post-treament reading. The corrected opacity for each treated cornea with the test item or positive control was calculated by subtracting the average change in opacity of the negative control corneas from the change in opacity of each test item or positive control treated cornea. The mean opacity value of each treatment group was calculated by averaging the corrected opacity values of the treated corneas for each treatment group.
PERMEABILITY
- Following the final opacity measurement, permeability of the cornea to Na-fluorescein (Sigma-Aldrich, Germany) was evaluated. The medium of both compartments (anterior compartment first) was removed. The posterior compartment was refilled with fresh cMEM. The anterior compartment was filled with 1 mL of 5 mg Na-fluorescein/mL cMEM solution (Sigma-Aldrich Chemie GmbH, Germany). The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the sodium-fluorescein solution over the entire cornea. Corneas were incubated in a horizontal position for 90 ± 5 minutes at 32 ± 1°C.
- After the incubation period, the medium in the posterior compartment of each holder was removed and placed into a sampling tube labelled according to holder number. 360 µL of the medium from each sampling tube was transferred to a 96-well plate. The optical density at 490 nm (OD490) of each sampling tube was measured in triplicate using a microplate reader (TECAN Infinite® M200 Pro Plate Reader). Any OD490 that was 1.500 or higher was diluted to bring the OD490 into the acceptable range (linearity up to OD490 of 1.500 was verified before the start of the experiment). OD490 values of less than 1.500 were used in the permeability calculation.
- The mean OD490 for each treatment was calculated using cMEM corrected OD490 values. If a dilution has been performed, the OD490 of each reading of the positive control and the test item was corrected for the mean negative control OD490 before the dilution factor was applied to the reading.
SCORING SYSTEM
The mean opacity and mean permeability values (OD490) were used for each treatment group to calculate an in vitro score:
In Vitro Irritancy Score (IVIS) = mean opacity value + (15 x mean OD490 value)
Additionally the opacity and permeability values were evaluated independently to determine whether the test item induced irritation through only one of the two endpoints.
DECISION CRITERIA
- A test item that induces an IVIS >55 is classified with Eye Irr. Cat. 1 in accordance with the CLP Regulation (and GHS)
- A test item that induces an IVIS ≤ 3 is not classified for Eye irritation/corrosion in accordance with the CLP Regulation (and GHS)
- For a test item that induces an IVIS of >3 - ≤55, no prediction on the classification can be made.
Results and discussion
In vitro
Results
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- Mean of 3 replicates
- Value:
- 203
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- - The individual in vitro irritancy scores for the negative controls ranged from -0.1 to 1.0. The corneas treated with the negative control item were clear after the 240 minutes of treatment.
- The corneas treated with the test item showed opacity values ranging from 190 to 203 and permeability values ranging from 0.404 to 0.501. The corneas were turbid after the 240 minutes of treatment with the test item. No pH effect of the test item was observed on the rinsing medium. The individual in vitro irritancy scores were 196, 203 and 210 for the corneas treated with the test item.
- The individual in vitro irritancy scores of the positive control were 213, 179 and 171. The corneas treated with the positive control were turbid after the 240 minutes of treatment.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control:
Yes (opacity: -0.1 - 0.8; permeability: 0.002 - 0.011)
- Acceptance criteria met for positive control:
Yes (IVIS: 188)
- Historical Control Data (period: Feb 2017 to Feb 2019)
Negative control Positive control
Opacity Permeability In vitro Irritancy Score In vitro Irritancy Score
Range -4.4 – 5.2 -0.011 - 0.081 -4.3 – 5.4 93 – 206
Mean 1.07 0.01 1.25 146.37
SD 1.96 0.02 1.99 25.92
n 109 109 108 108
SD = Standard deviation
n = Number of observations
Any other information on results incl. tables
Summary of results
Treatment |
Mean Opacity |
Mean Permeability |
Mean In vitro Irritation Score |
Negative control |
0.5 |
0.006 |
0.6 |
Positive control |
148 |
2.661 |
188 |
Test item |
196 |
0.443 |
203 |
Applicant's summary and conclusion
- Interpretation of results:
- other: Category 1 (irreversible effects on the eye) based on GHS and CLP criteria
- Conclusions:
- Based on an in vitro irritancy score of 203 in a Bovine Corneal Opacity and Permeability test, it is concluded that the substance is classified Category 1 (irreversible effects on the eye) for eye irritation/corrosion according to Regulation (EC) No. 1272/2008 (CLP).
- Executive summary:
Using the Bovine Corneal Opacity and Permeability test (BCOP test) the substance was screened for its eye hazard potential in accordance with OECD 437 and according to GLP principles. The solid test item was applied as a 20% (w/v) solution in physiological saline. Adequate negative and positive controls were included. The substance induced serious eye damage, resulting in a mean in vitro irritancy score of 203 after 4 hours of treatment. The acceptability criteria were met. Since the substance induced a mean IVIS > 55, in all 3 corneas, the substance is classified Category 1 (irreversible effects on the eye) for eye irritation/corrosion according to Regulation (EC) No. 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.